Healius Director Increases Shareholding, Signaling Confidence
I'm PortAI, I can summarize articles.
Healius Limited's Director John Mattick has increased his shareholding by acquiring 200,000 ordinary shares, signaling confidence in the company's future performance. The current analyst rating for Healius (AU:HLS) is a Hold with a price target of A$0.87. Healius operates in the healthcare sector, providing medical and diagnostic services across Australia, with a market cap of A$624.5M.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments